Assessing the effect of absorbable steroid sinus implant: a state-of-the-art systematic review.
Bioabsorbable implant
Propel
SEBI
Sinuva
Steroid-eluting
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
09 Mar 2024
09 Mar 2024
Historique:
received:
20
11
2023
accepted:
05
02
2024
medline:
9
3
2024
pubmed:
9
3
2024
entrez:
9
3
2024
Statut:
aheadofprint
Résumé
Endoscopic sinus surgery is not a definitive treatment for chronic rhinosinusitis (CRS). The use of sinus stents after surgery to maintain sinus patency and deliver local steroids has gained popularity. The first steroid-eluting bioabsorbable implant (SEBI) approved for this indication, later Propel, was developed in 2011. This state-of-the-art review aims to summarize the available evidence, as well as to point out potential pitfalls and lack of specific analyses to guide future research on this new therapeutic option. Pubmed (Medline), the Cochrane Library, EMBASE, SciELO. Nine research questions were defined: Are steroid-eluting Sinus implants useful for the control of CRS symptoms after surgery? Do they improve surgical field healing after CRS surgery? Do they decrease polyp regrowth after ESS? Do they decrease the need for ESS? Are they useful in symptom control as in-office procedure? Are they better than other steroid-impregnated resorbable materials? Do they have a positive impact on olfaction? Are they safe? Are they cost-effective? Retrieved articles were reviewed by two authors. Twenty nine studies were included: 3 metanalysis, 1 systematic review, 10 randomized clinical trials, 4 quasi-experimental studies, 1 retrospective cohort study, 4 cost studies, 3 case series and 2 expert consensus. The review encompassed a population of 3,012 patients treated with SEBI and 2826 controls. This is the first state-of-the-art review assessing steroid eluting bioabsorbable stent evidence. Despite the effort in recent years, still several questions remain unanswered. This review will hopefully guide future research efforts to better define the role of SEBI in the otolaryngology practice.
Identifiants
pubmed: 38459984
doi: 10.1007/s00405-024-08531-1
pii: 10.1007/s00405-024-08531-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Pleis JR, Lethbridge-Cejku M (2007) Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Vital Health Stat 10. 235:1–153
Metson RB, Gliklich RE (2000) Clinical outcomes in patients with chronic sinusitis. Laryngoscope 110(3 Pt 3):24–28
pubmed: 10718411
doi: 10.1097/00005537-200003002-00007
Baguley C, Brownlow A, Yeung K, Pratt E, Sacks R, Harvey R (2014) The fate of chronic rhinosinusitis sufferers after maximal medical therapy. Int Forum Allergy Rhinol 4(7):525–532
pubmed: 24610673
doi: 10.1002/alr.21315
Kennedy DW, Wright ED, Goldberg AN (2000) Objective and subjective outcomes in surgery for chronic sinusitis. Laryngoscope 110(3 Pt 3):29–31
pubmed: 10718412
doi: 10.1097/00005537-200003002-00008
Bugten V, Nordgård S, Steinsvåg S (2006) The effects of debridement after endoscopic sinus surgery. Laryngoscope 116(11):2037–2043
pubmed: 17075402
doi: 10.1097/01.mlg.0000241362.06072.83
Hardy JG, Lee SW, Wilson CG (1985) Intranasal drug delivery by spray and drops. J Pharm Pharmacol 37(5):294–297
pubmed: 2862235
doi: 10.1111/j.2042-7158.1985.tb05069.x
Murr AH, Smith TL, Hwang PH, Bhattacharyya N, Lanier BJ, Stambaugh JW et al (2011) Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol 1(1):23–32
pubmed: 22287304
doi: 10.1002/alr.20020
Forwith KD, Chandra RK, Yun PT, Miller SK, Jampel HD (2011) ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants. Laryngoscope 121(11):2473–2480
pubmed: 22020898
doi: 10.1002/lary.22228
Marple BF, Smith TL, Han JK, Gould AR, Jampel HD, Stambaugh JW et al (2012) Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg 146(6):1004–1011
pubmed: 22301107
doi: 10.1177/0194599811435968
Smith TL, Singh A, Luong A, Ow RA, Shotts SD, Sautter NB et al (2016) Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening. Laryngoscope 126(12):2659–2664
pubmed: 27363723
doi: 10.1002/lary.26140
Lavigne F, Miller SK, Gould AR, Lanier BJ, Romett JL (2014) Steroid-eluting sinus implant for in-office treatment of recurrent nasal polyposis: a prospective, multicenter study. Int Forum Allergy Rhinol 4(5):381–389
pubmed: 24599580
doi: 10.1002/alr.21309
Han JK, Forwith KD, Smith TL, Kern RC, Brown WJ, Miller SK et al (2014) RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol 4(11):861–870
pubmed: 25266981
doi: 10.1002/alr.21426
Forwith KD, Han JK, Stolovitzky JP, Yen DM, Chandra RK, Karanfilov B et al (2016) RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study. Int Forum Allergy Rhinol 6(6):573–581
pubmed: 26992115
doi: 10.1002/alr.21741
Kern RC, Stolovitzky JP, Silvers SL, Singh A, Lee JT, Yen DM et al (2018) A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol 8(4):471–481
pubmed: 29350840
pmcid: 5900893
doi: 10.1002/alr.22084
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(Suppl S29):1–464
pubmed: 32078669
Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU et al (2021) International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol 11(3):213–739
pubmed: 33236525
doi: 10.1002/alr.22741
Singh A, Luong AU, Fong KJ, Ow RA, Han JK, Gerencer R et al (2019) Bioabsorbable steroid-releasing implants in the frontal sinus ostia: a pooled analysis. Int Forum Allergy Rhinol 9(2):131–139
pubmed: 30431709
doi: 10.1002/alr.22238
Han JK, Marple BF, Smith TL, Murr AH, Lanier BJ, Stambaugh JW et al (2012) Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol 2(4):271–279
pubmed: 22550039
doi: 10.1002/alr.21044
Huang Z, Hwang P, Sun Y, Zhou B (2015) Steroid-eluting sinus stents for improving symptoms in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery. Cochrane Database Syst Rev 6:CD010436
Luong A, Ow RA, Singh A, Weiss RL, Han JK, Gerencer R et al (2018) Safety and effectiveness of a bioabsorbable steroid-releasing implant for the paranasal sinus ostia: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 144(1):28–35
pubmed: 29098299
Rawl JW, McQuitty RA, Khan MH, Reichert LK, Kuo YF, Chaaban MR (2020) Comparison of steroid-releasing stents vs nonabsorbable packing as middle meatal spacers. Int Forum Allergy Rhinol 10(3):328–333
pubmed: 31742932
doi: 10.1002/alr.22492
Huang Z, Zhou B, Wang D, Zang H, Zhang H, Wang H et al (2022) Comparison of bioabsorbable steroid-eluting sinus stents versus nasopore after endoscopic sinus surgery: a multicenter, randomized, controlled, single-blinded clinical trial. Ear Nose Throat J 101(4):260–267
pubmed: 32845808
doi: 10.1177/0145561320947632
Wang C, Yu L, Chu X, Wang K, Li J, Lai Y et al (2022) Short-term postoperative efficacy of steroid-eluting stents for eosinophilic chronic rhinosinusitis with nasal polyps: a randomized clinical trial. Int Forum Allergy Rhinol. 18:399
Matheny KE, Carter KB, Tseng EY, Fong KJ (2014) Safety, feasibility, and efficacy of placement of steroid-eluting bioabsorbable sinus implants in the office setting: a prospective case series. Int Forum Allergy Rhinol 4(10):808–815
pubmed: 25224654
doi: 10.1002/alr.21416
Ow R, Groppo E, Clutter D, Gawlicka AK (2014) Steroid-eluting sinus implant for in-office treatment of recurrent polyposis: a pharmacokinetic study. Int Forum Allergy Rhinol 4(10):816–822
pubmed: 25256638
doi: 10.1002/alr.21414
Hoffman V, Mortimer KM, Mulder K, Topuria I, Gliklich R, Kallman JE (2022) Real-world evidence analysis of the impact of steroid-eluting implants on healthcare resource use among chronic rhinosinusitis patients undergoing sinus surgery. Curr Med Res Opin 38(3):375–381
pubmed: 34951545
doi: 10.1080/03007995.2021.2022874
Rudmik L, Smith TL (2014) Economic evaluation of a steroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis. Otolaryngol Head Neck Surg 151(2):359–366
pubmed: 24796330
doi: 10.1177/0194599814533779
Rizzo JA, Rudmik L, Mallow PJ, Palli SR (2016) Budget impact analysis of bioabsorbable drug-eluting sinus implants following endoscopic sinus surgery. J Med Econ 19(9):829–835
pubmed: 27064315
doi: 10.1080/13696998.2016.1176577
Javanbakht M, Saleh H, Hemami MR, Branagan-Harris M, Boiano M (2020) A corticosteroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis: a UK-based cost-effectiveness analysis. Pharmacoecon Open 4(4):679–686
pubmed: 32048233
pmcid: 7688856
doi: 10.1007/s41669-020-00198-8
Ernst FR, Imhoff RJ, DeConde A, Manes RP (2019) Budget impact of a steroid-eluting sinus implant versus sinus surgery for adult chronic sinusitis patients with nasal polyps. J Manag Care Spec Pharm 25(8):941–950
pubmed: 30843454
Narwani V, Torabi SJ, Kasle DA, Patel RA, Lerner MZ, Manes RP (2022) Adverse events associated with corticosteroid-eluting sinus stents: a MAUDE database analysis. Otolaryngol Head Neck Surg 166(1):179–182
pubmed: 33848437
doi: 10.1177/01945998211006930
Huang Z, Huang Q, Zhou B, Ma J, Wang M, Dong Y (2019) Bioabsorbable steroid-eluting sinus stents for patients with refractory frontal diseases undergoing a revision Draf 3 procedure: a case series. Acta Otolaryngol 139(7):636–642
pubmed: 31124718
doi: 10.1080/00016489.2019.1592222
Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM et al (2016) International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol 6(Suppl 1):S22-209
pubmed: 26889651
Lee VS, Patel P, O’Brien D, Scangas GA, Campbell RG, Chandra R et al (2022) Indications for absorbable steroid-eluting sinus implants: viewpoint via the Delphi method. Int Forum Allergy Rhinol 12(10):1225–1231
pubmed: 35730163
pmcid: 10108565
doi: 10.1002/alr.23044
Aukema AAC, Mulder PGH, Fokkens WJ (2005) Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol 115(5):1017–1023
pubmed: 15867860
doi: 10.1016/j.jaci.2004.12.1144
Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D et al (2006) Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 118(1):128–133
pubmed: 16815148
doi: 10.1016/j.jaci.2006.03.012
Grayson JW, Harvey RJ (2019) Topical corticosteroid irrigations in chronic rhinosinusitis. Int Forum Allergy Rhinol 9(S1):S9-15
pubmed: 31087637
doi: 10.1002/alr.22331
Hox V, Bobic S, Callebaux I, Jorissen M, Hellings PW (2010) Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters. Rhinology 48(4):426–432
pubmed: 21442079
doi: 10.4193/Rhino10.049
Shah VN, Pasick LJ, Benito DA, Ghiam MK, D’Aguillo C (2022) Complications associated with PROPEL mometasone furoate bioabsorbable drug-eluting sinus stents from 2012 to 2020. Am J Rhinol Allergy 36(2):185–190
pubmed: 34342518
doi: 10.1177/19458924211035641
Li PMMC, Downie D, Hwang PH (2009) Controlled steroid delivery via bioabsorbable stent: safety and performance in a rabbit model. Am J Rhinol Allergy 23(6):591–596
pubmed: 19958608
doi: 10.2500/ajra.2009.23.3391
Lehmann AE, Raquib AR, Siddiqi SH, Meier J, Durand ML, Gray ST et al (2021) Prophylactic antibiotics after endoscopic sinus surgery for chronic rhinosinusitis: a randomized, double-blind, placebo-controlled noninferiority clinical trial. Int Forum Allergy Rhinol 11(7):1047–1055
pubmed: 33340285
doi: 10.1002/alr.22756
Moreno-Luna R, Martin-Jimenez DI, Callejon-Leblic MA, Gonzalez-Garcia J, Maza-Solano JM, Porras-Gonzalez C et al (2022) Usefulness of bilateral mucoplasty plus reboot surgery in severe type-2 chronic rhinosinusitis with nasal polyps. Rhinology 60(5):368–376
pubmed: 35818923
DeConde AS, Smith TL (2016) Outcomes after frontal sinus surgery: an evidence-based review. Otolaryngol Clin North Am 49(4):1019–1033
pubmed: 27450618
pmcid: 4964596
doi: 10.1016/j.otc.2016.03.024
Chandra RK, Palmer JN, Tangsujarittham T, Kennedy DW (2004) Factors associated with failure of frontal sinusotomy in the early follow-up period. Otolaryngol Head Neck Surg 131(4):514–518
pubmed: 15467628
doi: 10.1016/j.otohns.2004.03.022